Biobanking Market Projected to Reach $11.82 Billion by 2030, Growing at a 9.1% CAGR | MarketsandMarkets™

Market Growth: The global biobanking market is projected to grow from US$7.65 billion in 2025 to US$11.82 billion by 2030, with a CAGR of 9.1%, driven by advancements in personalized medicine and automation in sample handling.

Key Segments: The market is segmented into equipment (such as freezers and cryogenic storage) and consumables, with pharmaceutical and biotechnology companies expected to lead growth due to increased demand for biologics and advanced therapies.

Regional Insights: The Asia Pacific region is anticipated to experience the highest growth rate, fueled by enhanced research capabilities and a rising prevalence of chronic diseases, necessitating comprehensive biobanking solutions.

Major Players: Key players in the biobanking market include Thermo Fisher Scientific, Becton, Dickinson and Company, and PHC Holdings, each focusing on innovative solutions and sustainability to meet the evolving demands of biobanks globally.